A novel ligand containing two phosphaalkene moieties has been synthesized, which forms a palladium(II) complex whose crystal structure has been determined and whose reduction has been shown, by EPR spectroscopy, to take place on the ligand rather than on the metal.
No takes yet. Share an insight, caveat, or question.
Jouaiti et al. (1992) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: